(Q36745077)

16 August 2017

title

Bisphosphonates and jaw osteonecrosis: the UAMS experience (English)

1 reference

16 August 2017

Brett M Clarke

1

1 reference

16 August 2017

Jennings Boyette

2

1 reference

16 August 2017

Emre Vural

3

1 reference

16 August 2017

James Y Suen

4

1 reference

16 August 2017

Elias J Anaissie

5

1 reference

16 August 2017

Brendan C Stack

6

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Otolaryngology—Head and Neck Surgery

16 August 2017

published in

1 reference

16 August 2017

volume

136

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

396-400

1 reference

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Osteonecrosis of the jaw and bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Pathogenesis and natural history of osteonecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Osteonecrosis of the maxilla as a complication to chemotherapy: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

CASE 2. Osteonecrosis of the Jaws Associated With Bisphosphonate Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.11.008

10.1016/J.OTOHNS.2006.11.008

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference